TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NCI Reorganization Task Forces Near Decisions On New Division’s Makeup; Terry May Be Canidate May 25, 1979
TCL Archive In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review November 3, 1978